{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:53:28Z","timestamp":1791384808466,"version":"4.3.3"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","dmidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.diagmicrobio.2017.05.003","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T17:31:15Z","timestamp":1494523875000},"page":"335-341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Pseudomonas aeruginosa bacteraemia in patients with hematologic malignancies: risk factors, treatment and outcome"],"prefix":"10.1016","volume":"88","author":[{"given":"Polydoros","family":"Tofas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Samarkos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia-Theophano","family":"Piperaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Kosmidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna-Dionysia","family":"Triantafyllopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kotsopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aggeliki","family":"Pantazatou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavroula","family":"Perlorentzou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Poulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Vagia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George L.","family":"Daikos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"359","key":"10.1016\/j.diagmicrobio.2017.05.003_bb0005","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.3324\/haematol.2013.091330","article-title":"Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European conference on infections in leukemia (ECIL-4, 2011)","volume":"98","author":"Averbuch","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.diagmicrobio.2017.05.003_bb0010","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0014-2964(73)90108-4","article-title":"Advances in the management of Pseudomonas Aeruginosa infections in cancer patients","volume":"9","author":"Bodey","year":"1973","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2017.05.003_bb0015","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/QCO.0b013e32834cf054","article-title":"Fluoroquinolones, antimicrobial resistance and neutropenic cancer patients","volume":"24","author":"Bow","year":"2011","journal-title":"Curr Opin Infect Dis"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2017.05.003_bb0020","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00277-012-1424-3","article-title":"P. aeruginosa Bloodstream infections among hematological patients: an old or new question?","volume":"91","author":"Cattaneo","year":"2012","journal-title":"Ann Hematol"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2017.05.003_bb0025","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2017.05.003_bb0030","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/sj.thj.6200334","article-title":"Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxis","volume":"4","author":"Cherif","year":"2003","journal-title":"Hematol J"},{"key":"10.1016\/j.diagmicrobio.2017.05.003_bb0035","series-title":"22nd informational supplement","article-title":"Performance standards for antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2012"},{"issue":"Pt 12","key":"10.1016\/j.diagmicrobio.2017.05.003_bb0040","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1099\/jmm.0.073262-0","article-title":"Pseudomonas Aeruginosa bacteraemia: independent risk factors for mortality and impact of resistance on outcome","volume":"63","author":"Dantas","year":"2014","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.diagmicrobio.2017.05.003_bb0045","series-title":"Point prevalence survey of health-care associated infections and antimicrobial use in European acute care hospitals (may)","article-title":"Technical report","author":"ECDC","year":"2011"},{"key":"10.1016\/j.diagmicrobio.2017.05.003_bb0050","doi-asserted-by":"crossref","first-page":"791","DOI":"10.7326\/0003-4819-137-10-200211190-00007","article-title":"Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections","volume":"137","author":"Friedman","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diagmicrobio.2017.05.003_bb0055","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1093\/jac\/dkr166","article-title":"An update of the evolving epidemic of blaKPC-2-carrying Klebsiella pneumoniae in Greece (2009 \u201310)","volume":"66","author":"Giakkoupi","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2017.05.003_bb0060","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/1469-0691.12747","article-title":"Risk factors for carbapenem- resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study","volume":"20","author":"Giannella","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2017.05.003_bb0065","series-title":"The Sanford guide to antimicrobial therapy","year":"2012"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2017.05.003_bb0070","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1469-0691.1995.tb00455.x","article-title":"Risk factors and a clinical index for diagnosis of Pseudomonas Aeruginosa bacteremia","volume":"1","author":"Gransden","year":"1995","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2017.05.003_bb0075","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.3324\/haematol.2012.076349","article-title":"Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a global observational study","volume":"98","author":"Gratwohl","year":"2013","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2017.05.003_bb0080","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/21505594.2016.1156821","article-title":"Bloodstream infections in neutropenic cancer patients: a practical update","volume":"7","author":"Gustinetti","year":"2016","journal-title":"Virulence"},{"key":"10.1016\/j.diagmicrobio.2017.05.003_bb0085","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting am","volume":"36","author":"Horan","year":"2008","journal-title":"J Infect Control"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2017.05.003_bb0090","first-page":"690","article-title":"Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies","volume":"47","author":"Kara","year":"2015","journal-title":"Infect Dis (Lond)"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2017.05.003_bb0095","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1093\/jac\/dks270","article-title":"Emergence of resistance to fosfomycin used as adjunct therapy in KPC Klebsiella pneumoniae bacteraemia: report of three cases","volume":"67","author":"Karageorgopoulos","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2017.05.003_bb0100","series-title":"Evaluation of chemotherapeutic agents","first-page":"191","article-title":"The clinical evaluation of chemotherapeutic agents in cancer","author":"Karnofsky","year":"1949"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2017.05.003_bb0105","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.ajem.2015.03.058","article-title":"Different clinical presentation of community-onset bacteremia among neutropenic adults in the ED","volume":"33","author":"Lee","year":"2015","journal-title":"Am J Emerg Med"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2017.05.003_bb0110","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s00134-003-1662-x","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS international sepsis definitions conference","volume":"29","author":"Levy","year":"2003","journal-title":"Intensive Care Med"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2017.05.003_bb0115","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archinte.1962.03620240029006","article-title":"Gram negative bacteremia. I. Etiology and ecology","volume":"110","author":"McCabe","year":"1962","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.diagmicrobio.2017.05.003_bb0120","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jinf.2013.12.006","article-title":"Fourth European conference on infections in leukemia group ajvoEEIELN, Esgich\/Escmid. Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patients","volume":"68","author":"Mikulska","year":"2014","journal-title":"J Infect"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2017.05.003_bb0125","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10096-013-1819-7","article-title":"Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance","volume":"32","author":"Montassier","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2017.05.003_bb0130","first-page":"415","article-title":"Bacteremia in patients with hematological malignancies. Analysis of risk factors, etiological agents and prognostic indicators","volume":"82","author":"Pagano","year":"1997","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2017.05.003_bb0135","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/cid\/cit220","article-title":"Combination therapy for Pseudomonas Aeruginosa bacteremia: where do we stand?","volume":"57","author":"Paul","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2017.05.003_bb0140","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/cid\/cit223","article-title":"Effect of adequate single-drug vs combination antimicrobial therapy on mortality in Pseudomonas Aeruginosa bloodstream infections: a post hoc analysis of a prospective cohort","volume":"57","author":"Pena","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2017.05.003_bb0145","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkw459","article-title":"Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis","author":"Righi","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2017.05.003_bb0150","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s15010-014-0635-z","article-title":"Characteristics, risk factors and outcomes of adult cancer patients with extensively drug-resistant Pseudomonas Aeruginosa infections","volume":"42","author":"Samonis","year":"2014","journal-title":"Infection"},{"key":"10.1016\/j.diagmicrobio.2017.05.003_bb0155","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1056\/NEJM197105132841904","article-title":"Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia","volume":"284","author":"Schimpff","year":"1971","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2017.05.003_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/668770","article-title":"Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010","volume":"34","author":"Sievert","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2017.05.003_bb0165","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s005200050083","article-title":"Analysis of 553 episodes of monomicrobial bacteraemia in cancer patients: any association between risk factors and outcome to particular pathogen?","volume":"5","author":"Spanik","year":"1997","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.diagmicrobio.2017.05.003_bb0170","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/QCO.0000000000000038","article-title":"Antimicrobial-resistant gram-negative bacteria in febrile neutropenic patients with cancer: current epidemiology and clinical impact","volume":"27","author":"Trecarichi","year":"2014","journal-title":"Curr Opin Infect Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2017.05.003_bb0175","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.3324\/haematol.2010.036640","article-title":"Multidrug resistant Pseudomonas Aeruginosa bloodstream infection in adult patients with hematologic malignancies","volume":"96","author":"Trecarichi","year":"2011","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2017.05.003_bb0180","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1017\/S0950268810003055","article-title":"Multidrug-resistant Pseudomonas Aeruginosa bloodstream infections: risk factors and mortality","volume":"139","author":"Tumbarello","year":"2011","journal-title":"Epidemiol Infect"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2017.05.003_bb0185","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ijantimicag.2012.12.006","article-title":"Beta-lactam plus aminoglycoside or fluoroquinolone combination versus beta-lactam monotherapy for Pseudomonas Aeruginosa infections: a meta-analysis","volume":"41","author":"Vardakas","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2017.05.003_bb0190","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1093\/jac\/dku305","article-title":"A multicentre cohort study on colonization and infection with ESBL producing Enterobacteriaceae in high-risk patients with haematological malignancies","volume":"69","author":"Vehreschild","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. 4","key":"10.1016\/j.diagmicrobio.2017.05.003_bb0195","doi-asserted-by":"crossref","first-page":"S240","DOI":"10.1086\/427329","article-title":"Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification","volume":"40","author":"Viscoli","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2017.05.003_bb0200","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/jac\/dkl239","article-title":"The influence of metallo-beta-lactamase production on mortality in nosocomial Pseudomonas Aeruginosa infections","volume":"58","author":"Zavascki","year":"2006","journal-title":"J Antimicrob Chemother"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889317301487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889317301487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T23:26:12Z","timestamp":1535844372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889317301487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0732889317301487"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2017.05.003","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pseudomonas aeruginosa bacteraemia in patients with hematologic malignancies: risk factors, treatment and outcome","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2017.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}